Detalles de la búsqueda
1.
Genetic variation associated with bortezomib-induced peripheral neuropathy.
Pharmacogenet Genomics
; 21(3): 121-9, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21228734
2.
Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. melphalan-prednisone in the phase III VISTA trial in multiple myeloma.
Eur J Haematol
; 86(5): 372-84, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21366694
3.
Blood Biomarker Landscape in Patients with High-risk Nonmetastatic Castration-Resistant Prostate Cancer Treated with Apalutamide and Androgen-Deprivation Therapy as They Progress to Metastatic Disease.
Clin Cancer Res
; 27(16): 4539-4548, 2021 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34112710
4.
Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate Cancer.
JAMA Oncol
; 7(7): 1005-1014, 2021 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34081076
5.
Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts.
Clin Cancer Res
; 23(9): 2301-2312, 2017 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27993966
6.
Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate.
Clin Cancer Res
; 21(7): 1621-7, 2015 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25593303
Resultados
1 -
6
de 6
1
Próxima >
>>